U.S. Markets closed

Amarin Shares Show Heart as Anti-Cholesterol Drug Firm Bucks Market Rout

Amarin's stock jumped after SVB Leerink upped its rating on the biotech's stock to outperform, saying a recent double-digit decline offers a buying opportunity.